Your session is about to expire
← Back to Search
Sensor
MicroTrend System for Low Blood Flow
N/A
Waitlist Available
Led By Raul J Gazmuri, MD, PhD
Research Sponsored by ExoStat Medical, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4-6 hours
Awards & highlights
Study Summary
This trial is testing a new system that monitors carbon dioxide levels in the blood, to see if it is safe and effective.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4-6 hours
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4-6 hours
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Correlation between POMCO2
Trial Design
1Treatment groups
Experimental Treatment
Group I: MicroTrend SystemExperimental Treatment1 Intervention
MicroTrend System is placed onto the subject's cheek and the subject will actively participate in the study for up to 6 hours, with up to 4 hours of sensor monitoring.
Find a Location
Who is running the clinical trial?
ExoStat Medical, Inc.Lead Sponsor
Bright Research PartnersIndustry Sponsor
13 Previous Clinical Trials
1,747 Total Patients Enrolled
Raul J Gazmuri, MD, PhDPrincipal InvestigatorCaptain James A. Lovell Federal Health Care Center
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger